GK Wealth Management’s Castle Biosciences CSTL Stock Holding History

GK Wealth Management’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.6K	Buy	+214	New	+$6.46K	﹤0.01%	948

Other funds holding CSTL

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

FBT

First Bank & Trust Brookings, South Dakota $687M AUM 18.35% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

Oak Harvest Investment Services Houston, Texas $1.07B AUM 32.83% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GK Wealth Management's CSTL Position: Q3 2026 in Review

GK Wealth Management opened a new position in Castle Biosciences (CSTL) in Q3 2026: 214 shares worth $7.6K. The stake represents ﹤0.01% of the portfolio and ranks #948 among its holdings.

17 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

GK Wealth Management held 214 shares of Castle Biosciences worth $7.6K as of Q3 2026.
Castle Biosciences was a new GK Wealth Management position in Q3 2026.
Castle Biosciences made up ﹤0.01% of GK Wealth Management's portfolio in Q3 2026, its #948 holding.
17 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.